Mark A. Muesing
Impact in
- Virology top 0.2%
- HIV Research and Treatment
- Infectious Diseases top 1%
- HIV/AIDS drug development and treatment
Papers in
- Virology 24
- HIV Research and Treatment 24
-
- HIV/AIDS drug development and treatment 23
- Co-authors
- M. WISKERCHEN (5 shared papers)Lubbertus C. F. Mulder (5 shared papers)Charles V. Benton (1 shared paper)Daniel J. Capon (1 shared paper)Cirilo D. Cabradilla (1 shared paper)Laurence A. Lasky (1 shared paper)Douglas H. Smith (1 shared paper)Barry Polisky (3 shared papers)
- Journals
- Journal of Virology (5 papers)Bioorganic & Medicinal Chemistry Letters (5 papers)Journal of Medicinal Chemistry (3 papers)Proceedings of the National Academy of Sciences (3 papers)Virology (3 papers)
- Partner nations
- United StatesSwitzerlandPoland
In The Last Decade
Mark A. Muesing
35 papers receiving 3.7k citations
Mark A. Muesing's Hit Papers
Peers
Comparison fields: 5 of 104
- Virology 2.0k
- Infectious Diseases 1.3k
- Immunology 705
- Molecular Biology 1.9k
- Genetics 537
Countries citing papers authored by Mark A. Muesing
This map shows the geographic impact of Mark A. Muesing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Muesing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Muesing more than expected).
Fields of papers citing papers by Mark A. Muesing
This network shows the impact of papers produced by Mark A. Muesing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Muesing. The network helps show where Mark A. Muesing may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark A. Muesing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein Hit paper breakdown → | 1987 | 612 |
| 2 | Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus Hit paper breakdown → | 1985 | 599 |
| 3 | 1997 | 485 | |
| 4 | 2005 | 276 | |
| 5 | 2002 | 236 | |
| 6 | 1995 | 220 | |
| 7 | 1982 | 168 | |
| 8 | 1987 | 132 | |
| 9 | 1999 | 113 | |
| 10 | 1996 | 104 | |
| 11 | 1997 | 91 | |
| 12 | 1981 | 86 | |
| 13 | 2000 | 83 | |
| 14 | 2009 | 71 | |
| 15 | 1982 | 64 | |
| 16 | 2002 | 63 | |
| 17 | 1998 | 49 | |
| 18 | 2016 | 40 | |
| 19 | 2006 | 39 | |
| 20 | 2011 | 38 |
About Mark A. Muesing
Mark A. Muesing is a scholar working on Virology, Infectious Diseases, Molecular Biology, Organic Chemistry and Epidemiology, having authored 37 papers that have together received 3.9k indexed citations. Recurring topics across this work include HIV Research and Treatment (24 papers), HIV/AIDS drug development and treatment (23 papers), Biochemical and Molecular Research (8 papers), Click Chemistry and Applications (6 papers), Chemical Synthesis and Analysis (5 papers), Cytomegalovirus and herpesvirus research (4 papers), Bacterial Genetics and Biotechnology (4 papers) and DNA Repair Mechanisms (3 papers). The work is most often cited by research in Virology (2.0k citations), Infectious Diseases (1.3k citations), Immunology (705 citations), Molecular Biology (1.9k citations) and Genetics (537 citations). Mark A. Muesing has collaborated with scholars based in United States, Switzerland and Poland. Frequent co-authors include M. WISKERCHEN, Lubbertus C. F. Mulder, Charles V. Benton, Daniel J. Capon, Cirilo D. Cabradilla, Laurence A. Lasky, Douglas H. Smith, Barry Polisky, Gianni Cesareni and Paul D. Bieniasz. Their work appears in journals such as Journal of Virology, Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Proceedings of the National Academy of Sciences and Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.